Definitive Contract 75F40119C10079

Award Date 9/20/19
Potential Completion Date 9/19/22
Potential Value $793K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
34
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,079.52 firm fixed-price delivery order is for the supply of fluticasone propionate 50 mcg nasal spray, a common medication used to treat nasal congestion and allergies. The contract has a completion date of September 4, 2024 and was awarded on September 3, 2024. It is not designated as a set-aside contract....
This federal contract award is for the procurement of fluticasone propionate 50 mcg nasal spray (16 grams) by the Defense Logistics Agency (DLA). The $1,010.02 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 7, 2025 with a completion date of January 8, 2025. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with...
This is a $2,210,154.51 cost-plus-fixed-fee contract awarded by the Food and Drug Administration (FDA) to Applied Research Associates, Inc. (ARA), a for-profit S corporation based in Albuquerque, New Mexico. The contract is for a scientific study on the development of physiological models and software tools for health risk evaluation of e-cigarettes. This work falls under the FDA's Broad Agency Announcement (BAA) program for developing such models and tools. The contract does not have a...
This is a $5,629,115.00 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Aptargroup Inc. for research related to environmentally friendly propellants in metered dose inhalers. The contract has a period of performance through September 20, 2027. There is no set-aside designation for this award. Aptargroup Inc. is the prime contractor, and the contract does not mention any major subcontractors. The FDA oversees the regulation of...
The Department of Health and Human Services Food and Drug Administration awarded a $45,275 purchase order to Proveris Scientific Corp of Hudson, Massachusetts for CDER-2023-117758 OMUFA - NASAL SPRAY ACTUATOR. The firm fixed price contract calls for Proveris Scientific to provide nasal spray actuators to the FDA's Center for Drug Evaluation and Research in support of the agency's regulatory programs. The contract runs from August 2023 through September 2024 and has been set aside for total small...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,086.00 firm fixed-price delivery order is for the supply of Fluticasone Propionate 50 mcg Nasal Spray, a pharmaceutical product. The contract has an ultimate completion date of August 27, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts, including...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $12,914.84 firm fixed-price contract is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of January 10, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp Corporate Office Division for the supply of fluticasone propionate 50 mcg nasal spray. The $1,044.84 firm fixed price contract has an ultimate completion date of September 4, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with significant Indefinite Delivery Contracts (IDCs) with the DLA...
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $4,348.32 and a completion date of February 13, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,521.55, is for the provision of a fluticasone propionate nasal spray product to support federal healthcare programs. The contract has a fixed price arrangement and an ultimate completion date of May 15, 2024. This appears to be a non-set-aside contract, awarded through open...

The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price Definitive Contract to Applied Research Associates, Inc. (ARA) worth $793,400.00 to conduct modifications and improvements to hybrid computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) models for predicting nasal corticosteroid deposition, absorption, and bioavailability. The contract has a completion date of September 19, 2022 and was awarded on September 20, 2019. No set-aside designations were provided.

As a subcontractor, The Medical College of Wisconsin, Inc. (MCW) will perform tasks related to conducting CFD simulations of nasal spray deposition patterns in healthy and rhinitic adult models, as well as CFD-PBPK simulations of fluticasone furoate and triamcinolone acetonide. MCW will provide the CFD results to ARA to incorporate into the PBPK model simulations. MCW holds several indefinite delivery/indefinite quantity (IDIQ) contracts with federal agencies including the National Highway Traffic Safety Administration and Department of Veterans Affairs to provide various research and testing services.

Generated 3/23/24, 8:57 PM